Logo image of KMDA

KAMADA LTD (KMDA) Stock Price, Quote, News and Overview

NASDAQ:KMDA - Nasdaq - IL0010941198 - Common Stock - Currency: USD

6.88  -0.11 (-1.57%)

KMDA Quote, Performance and Key Statistics

KAMADA LTD

NASDAQ:KMDA (5/9/2025, 8:04:44 PM)

6.88

-0.11 (-1.57%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High9.15
52 Week Low4.74
Market Cap395.67M
Shares57.51M
Float31.27M
Yearly DividendN/A
Dividend Yield2.91%
PE26.46
Fwd PE22.67
Earnings (Next)05-14 2025-05-14/bmo
IPO08-01 2005-08-01


KMDA short term performance overview.The bars show the price performance of KMDA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 -5 10 -10 15

KMDA long term performance overview.The bars show the price performance of KMDA in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30 40 50

The current stock price of KMDA is 6.88 USD. In the past month the price increased by 16.41%. In the past year, price increased by 24.3%.

KAMADA LTD / KMDA Daily stock chart

KMDA Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 17.97 326.55B
AMGN AMGEN INC 12.81 142.94B
GILD GILEAD SCIENCES INC 12.52 120.65B
VRTX VERTEX PHARMACEUTICALS INC N/A 109.26B
REGN REGENERON PHARMACEUTICALS 11.91 56.98B
ARGX ARGENX SE - ADR 93.64 33.56B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 32.67B
ONC BEIGENE LTD-ADR 5.79 25.01B
BNTX BIONTECH SE-ADR N/A 22.30B
NTRA NATERA INC N/A 20.66B
SMMT SUMMIT THERAPEUTICS INC N/A 17.79B
BIIB BIOGEN INC 7.47 17.32B

About KMDA

Company Profile

KMDA logo image Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Company Info

KAMADA LTD

2 Holtzman St., Science Park

Rehovot 7670402 IL

CEO: Amir London

Employees: 420

KMDA Company Website

KMDA Investor Relations

Phone: 97289406472

KAMADA LTD / KMDA FAQ

What is the stock price of KAMADA LTD today?

The current stock price of KMDA is 6.88 USD. The price decreased by -1.57% in the last trading session.


What is the ticker symbol for KAMADA LTD stock?

The exchange symbol of KAMADA LTD is KMDA and it is listed on the Nasdaq exchange.


On which exchange is KMDA stock listed?

KMDA stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for KAMADA LTD stock?

9 analysts have analysed KMDA and the average price target is 15.05 USD. This implies a price increase of 118.68% is expected in the next year compared to the current price of 6.88. Check the KAMADA LTD stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is KAMADA LTD worth?

KAMADA LTD (KMDA) has a market capitalization of 395.67M USD. This makes KMDA a Small Cap stock.


How many employees does KAMADA LTD have?

KAMADA LTD (KMDA) currently has 420 employees.


What are the support and resistance levels for KAMADA LTD (KMDA) stock?

KAMADA LTD (KMDA) has a support level at 6.8 and a resistance level at 7. Check the full technical report for a detailed analysis of KMDA support and resistance levels.


Is KAMADA LTD (KMDA) expected to grow?

The Revenue of KAMADA LTD (KMDA) is expected to grow by 11.6% in the next year. Check the estimates tab for more information on the KMDA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy KAMADA LTD (KMDA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does KAMADA LTD (KMDA) stock pay dividends?

KAMADA LTD (KMDA) has a dividend yield of 2.91%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of KMDA dividend history, reliability and sustainability.


When does KAMADA LTD (KMDA) report earnings?

KAMADA LTD (KMDA) will report earnings on 2025-05-14, before the market open.


What is the Price/Earnings (PE) ratio of KAMADA LTD (KMDA)?

The PE ratio for KAMADA LTD (KMDA) is 26.46. This is based on the reported non-GAAP earnings per share of 0.26 and the current share price of 6.88 USD. Check the full fundamental report for a full analysis of the valuation metrics for KMDA.


What is the Short Interest ratio of KAMADA LTD (KMDA) stock?

The outstanding short interest for KAMADA LTD (KMDA) is 0.07% of its float. Check the ownership tab for more information on the KMDA short interest.


KMDA Technical Analysis

ChartMill assigns a technical rating of 7 / 10 to KMDA. When comparing the yearly performance of all stocks, KMDA is one of the better performing stocks in the market, outperforming 80.5% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

KMDA Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to KMDA. KMDA gets an excellent profitability rating and is at the same time showing great financial health properties.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

KMDA Financial Highlights

Over the last trailing twelve months KMDA reported a non-GAAP Earnings per Share(EPS) of 0.26. The EPS increased by 73.33% compared to the year before.


Industry RankSector Rank
PM (TTM) 8.99%
ROA 3.88%
ROE 5.57%
Debt/Equity 0.04
Chartmill High Growth Momentum
EPS Q2Q%-22.22%
Sales Q2Q%7.06%
EPS 1Y (TTM)73.33%
Revenue 1Y (TTM)12.94%

KMDA Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to KMDA. The Buy consensus is the average rating of analysts ratings from 9 analysts.

For the next year, analysts expect an EPS growth of 16.71% and a revenue growth 11.6% for KMDA


Ownership
Inst Owners11.62%
Ins Owners2.34%
Short Float %0.07%
Short Ratio0.16
Analysts
Analysts84.44
Price Target15.05 (118.75%)
EPS Next Y16.71%
Revenue Next Year11.6%